Clinical trial
Sublingual Methadone for the Management of Cancer-related Procedure Pain in…
NCT00351637 · Alberta Health services, Other · Terminated
Key facts
| NCT number | NCT00351637 |
|---|---|
| Title | Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients |
| Official title | Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients: a Phase II Multicenter, Open Label, Feasibility Study |
| Lead sponsor | Alberta Health services, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cancer, Pain |
| Intervention type | Drug |
| Interventions | Sublingual Methadone |
| Enrollment | 60 |
| Start date | Dec 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Jul 13, 2006 |
| Last update posted | Jan 19, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: